fig1

Leveraging biomimetic synthesis strategy for next-generation dendritic cell nanovaccines

Figure 1. (A) Illustration of the process for preparing ASPIRE from DCs. DCNVs have nanoscale size, good stability, and a homing effect, thus enabling ASPIRE to be rapidly enriched in the lymphatic system. (B) Schematic describing ASPIRE for antigen self-presentation and immunosuppression blockade. ASPIRE: Antigen self-presentation and immunosuppression reversal; DCs: dendritic cells. Reproduced with permission. Copyright 2022, Springer Nature.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/